AcelRx Pharmaceuticals Financials

ACRXDelisted Stock  USD 0.86  0.08  10.26%   
Based on the key indicators related to AcelRx Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, AcelRx Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
With this module, you can analyze AcelRx financials for your investing period. You should be able to track the changes in AcelRx Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past AcelRx Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AcelRx Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in AcelRx Pharmaceuticals' assets may result in an increase in income on the income statement.
Evaluating AcelRx Pharmaceuticals' financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of AcelRx Pharmaceuticals' profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the AcelRx Pharmaceuticals' relative financial performance

Chance Of Distress

Over 100

 
100  
 
Zero
Dangerous
AcelRx Pharmaceuticals has more than 100 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for AcelRx Pharmaceuticals stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, AcelRx Pharmaceuticals' odds of distress score SHOULD NOT be confused with the real chance of AcelRx Pharmaceuticals filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as AcelRx is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include AcelRx Pharmaceuticals' liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in AcelRx Pharmaceuticals' official financial statements usually reflect AcelRx Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AcelRx Pharmaceuticals. For example, before you start analyzing numbers published by AcelRx accountants, it's critical to develop an understanding of what AcelRx Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of AcelRx Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AcelRx Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AcelRx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AcelRx Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of AcelRx Pharmaceuticals' management manipulating its earnings.

AcelRx Pharmaceuticals Company Summary

AcelRx Pharmaceuticals competes with Visionary Education, LGI Homes, Boston Properties, Postal Realty, and Haier Smart. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California. Acelrx Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001427925
ISINUS00444T1007
RegionNorth America
Business Address25821 Industrial Boulevard,
New SymbolTLPH
SectorPharmaceuticals
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.acelrx.com
Phone650 216 3500
CurrencyUSD - US Dollar
You should never invest in AcelRx Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AcelRx Stock, because this is throwing your money away. Analyzing the key information contained in AcelRx Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

AcelRx Pharmaceuticals Key Financial Ratios

Generally speaking, AcelRx Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from AcelRx Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of AcelRx Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AcelRx Pharmaceuticals reports annually and quarterly.

AcelRx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AcelRx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare AcelRx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AcelRx Pharmaceuticals competition to find correlations between indicators driving AcelRx Pharmaceuticals's intrinsic value. More Info.
AcelRx Pharmaceuticals is rated third in price to earning category among related companies. It is number one stock in short ratio category among related companies fabricating about  11.69  of Short Ratio per Price To Earning. . Comparative valuation analysis is a catch-all model that can be used if you cannot value AcelRx Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AcelRx Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AcelRx Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

AcelRx Pharmaceuticals Market Pulse

 Quote0.86
 Change(%)  10.26 
 Change0.08 
 Open0.78
 Low0.78
 High0.88
 Volume0
 ExchangeNASDAQ

About AcelRx Pharmaceuticals Financials

What exactly are AcelRx Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AcelRx Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential AcelRx Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AcelRx Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in AcelRx Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AcelRx Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze AcelRx Pharmaceuticals Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as AcelRx Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of AcelRx has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if AcelRx Pharmaceuticals' financials are consistent with your investment objective using the following steps:
  • Review AcelRx Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand AcelRx Pharmaceuticals' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare AcelRx Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if AcelRx Pharmaceuticals' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

AcelRx Pharmaceuticals March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AcelRx Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AcelRx Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of AcelRx Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing AcelRx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AcelRx Pharmaceuticals's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in AcelRx Stock

If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years